Pan-inhibition of the GPC3/Wnt/Fzd7, LRP6, and ROR2 Signaling Axis via KOH-Mediated Selective Ionic Denaturation in Lung Squamous Cell Carcinoma (LUSC)

Pan-inhibition of the GPC3/Wnt/Fzd7, LRP6, and ROR2 Signaling Axis via KOH-Mediated Selective Ionic Denaturation in Lung Squamous Cell Carcinoma (LUSC) | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Pan-inhibition of the GPC3/Wnt/Fzd7, LRP6, and ROR2 Signaling Axis via KOH-Mediated Selective Ionic Denaturation in Lung Squamous Cell Carcinoma (LUSC) Emin Zumrutdal This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-9381892/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Objective: This study aims to investigate, at an in silico level, the potential for "upstream" sabotage of the GPC/Wnt/Frizzled signaling axis—a pathway of critical importance in lung squamous cell carcinoma (LUSC)—via potassium hydroxide (KOH)-mediated ionic denaturation. Material and Methods: In this study, the interactions between the extracellular domains (ECDs) of seven critical protein targets within the LUSC signaling axis (GPC3, GPC5, Wnt3a, Wnt5a, Fzd7, LRP6, and ROR2) and KOH along with its ionic components (K + , OH - ) were analyzed using systematic molecular docking simulations and Ligand Efficiency (LE) metrics. Despite their structural similarities, the pro-tumoral GPC3 and anti-tumoral GPC5 proteins—which possess opposing biological roles—were specifically examined in terms of the ionic agent's target selectivity and conformational interaction geometry. The affinity of ions for strategic disulfide bridges was subjected to a comprehensive evaluation based on thermodynamic stability parameters. Results: Molecular docking analyses revealed that KOH and its ionic components (K + , OH - ) establish thermodynamically spontaneous (exergonic) interactions with all target ligand and receptor complexes within the GPC/Wnt/Fzd axis. Exergonic binding profiles were observed across all seven disulfide bonds in both the GPC3 and GPC5 proteins. Notably, in the pro-tumoral GPC3 protein, the K + ion approached the Cys262 residue at a precise, topologically perpendicular angle (91.12°). This geometric orientation was identified as a critical mechanism triggering the selective denaturation of the strategic disulfide bridge, interacting with a Ligand Efficiency (LE) of -0.739 an exceptionally high value for a single ionic component. In contrast, the anti-tumoral GPC5 model exhibited significantly increased angular deviations, indicating structural resistance to the ionic disruption. The negative binding energies and high LE values detected across all complexes confirm that KOH exhibits substantial structural sabotage capacity on target disulfide bridges, despite its low molecular weight. Conclusion: These findings indicate that KOH possesses the potential to act as a molecular agent with high target specificity, capable of structurally modulating the signal transduction pathway. This study provides a theoretical biochemical framework for the development of low-cost, high-efficiency "Ionic Therapy" protocols in the treatment of LUSC. Cancer Biology Computational Biology Bioinformatics Lung Squamous Cell Carcinoma (LUSC) Ligand Efficiency (LE) Glypican-3(GPC3) Disulfide Bridge Sabotage Selective Modulation Wnt/ β-Catenin Signaling Potassium Hydroxide Full Text Additional Declarations The authors declare no competing interests. Supplementary Files supplementfiles.zip Supplementary_Information.zip Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-9381892","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":621141192,"identity":"58042f78-d9ba-444e-9a36-7d51d05e7eb2","order_by":0,"name":"Emin Zumrutdal","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA0UlEQVRIiWNgGAWjYBADxgZ25gNAkngdBowNzGwJJGvhMSBOCz//GdPNlW1/ZPubeb5J/NxhI8fAfvjoBnxaJBvOmN0822ZgPOMw7zbJ3jNpxgw8aWk38LroYI/ZzcY2g8QGoBYJ3rbDiQ0SPGZ4tdgf5oFomX+Y55nkX2K0GLBBtWw4zMMmTZQtEmfYym42nDM23niYzdhati3NmI2QX/j7D2+72VAmJzvvePPDm2/bbOT42Q8fw6sFGbBIgEg2YpWDAPMHUlSPglEwCkbByAEAgm1LN7v7NsMAAAAASUVORK5CYII=","orcid":"","institution":"Cukurova Technopark","correspondingAuthor":true,"prefix":"","firstName":"Emin","middleName":"","lastName":"Zumrutdal","suffix":""}],"badges":[],"createdAt":"2026-04-10 16:55:27","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-9381892/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-9381892/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":106961156,"identity":"fc34b230-49d8-4a9a-9336-55ef304a65cd","added_by":"auto","created_at":"2026-04-15 09:24:31","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":926360,"visible":true,"origin":"","legend":"","description":"","filename":"ORIGINALARTICLE.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9381892/v1_covered_6ff4735c-5b64-4917-b955-39e7540418b1.pdf"},{"id":106886863,"identity":"4572fb6e-ad3a-459a-8e3e-f3e8cda103bd","added_by":"auto","created_at":"2026-04-14 12:43:05","extension":"zip","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":1576784,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary_Information.zip\u003c/p\u003e","description":"","filename":"supplementfiles.zip","url":"https://assets-eu.researchsquare.com/files/rs-9381892/v1/b0c56e4673b2dff10f1bfad3.zip"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003e\u003cstrong\u003ePan-inhibition of the GPC3/Wnt/Fzd7, LRP6, and ROR2 Signaling Axis via KOH-Mediated Selective Ionic Denaturation in Lung Squamous Cell Carcinoma (LUSC)\u003c/strong\u003e\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"Cukurova Technopark","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Lung Squamous Cell Carcinoma (LUSC), Ligand Efficiency (LE), Glypican-3(GPC3), Disulfide Bridge Sabotage, Selective Modulation, Wnt/ β-Catenin Signaling, Potassium Hydroxide","lastPublishedDoi":"10.21203/rs.3.rs-9381892/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-9381892/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eObjective:\u003c/strong\u003e This study aims to investigate, at an \u003cem\u003ein silico\u003c/em\u003e level, the potential for \"upstream\" sabotage of the GPC/Wnt/Frizzled signaling axis—a pathway of critical importance in lung squamous cell carcinoma (LUSC)—via potassium hydroxide (KOH)-mediated ionic denaturation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMaterial and Methods:\u003c/strong\u003e In this study, the interactions between the extracellular domains (ECDs) of seven critical protein targets within the LUSC signaling axis (GPC3, GPC5, Wnt3a, Wnt5a, Fzd7, LRP6, and ROR2) and KOH along with its ionic components (K\u003csup\u003e+\u003c/sup\u003e, OH\u003csup\u003e-\u003c/sup\u003e) were analyzed using systematic molecular docking simulations and Ligand Efficiency (LE) metrics. Despite their structural similarities, the pro-tumoral GPC3 and anti-tumoral GPC5 proteins—which possess opposing biological roles—were specifically examined in terms of the ionic agent's target selectivity and conformational interaction geometry. The affinity of ions for strategic disulfide bridges was subjected to a comprehensive evaluation based on thermodynamic stability parameters.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults: \u003c/strong\u003eMolecular docking analyses revealed that KOH and its ionic components (K\u003csup\u003e+\u003c/sup\u003e, OH\u003csup\u003e-\u003c/sup\u003e)\u0026nbsp; establish thermodynamically spontaneous (exergonic) interactions with all target ligand and receptor complexes within the GPC/Wnt/Fzd axis. Exergonic binding profiles were observed across all seven disulfide bonds in both the GPC3 and GPC5 proteins. Notably, in the pro-tumoral GPC3 protein, the K\u003csup\u003e+\u003c/sup\u003e ion approached the Cys262 residue at a precise, topologically perpendicular angle (91.12°). This geometric orientation was identified as a critical mechanism triggering the selective denaturation of the strategic disulfide bridge, interacting with a Ligand Efficiency (LE) of -0.739 an exceptionally high value for a single ionic component. In contrast, the anti-tumoral GPC5 model exhibited significantly increased angular deviations, indicating structural resistance to the ionic disruption.\u003c/p\u003e\n\u003cp\u003eThe negative binding energies and high LE values detected across all complexes confirm that KOH exhibits substantial structural sabotage capacity on target disulfide bridges, despite its low molecular weight.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion:\u003c/strong\u003e These findings indicate that KOH possesses the potential to act as a molecular agent with high target specificity, capable of structurally modulating the signal transduction pathway. This study provides a theoretical biochemical framework for the development of low-cost, high-efficiency \"Ionic Therapy\" protocols in the treatment of LUSC.\u003c/p\u003e","manuscriptTitle":"Pan-inhibition of the GPC3/Wnt/Fzd7, LRP6, and ROR2 Signaling Axis via KOH-Mediated Selective Ionic Denaturation in Lung Squamous Cell Carcinoma (LUSC)","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-04-14 12:42:57","doi":"10.21203/rs.3.rs-9381892/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"6ee04adb-a3ff-4d07-b521-fc974d6a0912","owner":[],"postedDate":"April 14th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":66109350,"name":"Cancer Biology"},{"id":66109351,"name":"Computational Biology"},{"id":66109352,"name":"Bioinformatics"}],"tags":[],"updatedAt":"2026-04-14T12:42:57+00:00","versionOfRecord":[],"versionCreatedAt":"2026-04-14 12:42:57","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-9381892","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-9381892","identity":"rs-9381892","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}